Every material Form 8-K Bunge Global filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Bunge Global SA and certain subsidiaries amended their existing trade receivables securitization program on October 30, 2026, extending its termination date by 364 days to December 13, 2027. The filing says other key terms were substantially unchanged and does not disclose a dollar size for the program.
Amendment dated October 30, 2026 extends the program's termination date by 364 days to December 13, 2027.
Purchasers permitted a merger of one Dutch originator into another Dutch subsidiary, which survives as a Dutch originator.
Bunge's recourse is limited to its first loss position as subordinated lender, apart from repurchase obligations for ineligible receivables.
Bunge reported third quarter 2026 results, with net income attributable to Bunge of $318 million, up from $166 million a year earlier, and net sales of $23,804 million versus $22,155 million. The company kept its full-year 2026 adjusted EPS outlook at $9.25 to $9.75, while expecting slightly lower Soybean Processing and Refining results and lower Tropical Oils and Specialty Ingredients results than previously outlined, which matters to shareholders because higher profit came with an unchanged earnings target.
Q3 GAAP diluted EPS from continuing operations was $1.64 versus $0.86; adjusted EPS was $2.56 versus $2.27.
Nine-month adjusted EPS was $6.38 versus $5.56, while cash used for operating activities was $2,302 million versus $503 million.
Q3 included $82 million of charges tied to the announced sale of two sugarcane mills in Brazil.
Adjusted annual effective tax rate outlook is 23% to 25%; net interest expense outlook is $640 to $670 million.
Bunge Global SA said its Chief Legal Officer, Joseph Podwika, will step down effective November 9, 2026, when Ignacio Walker takes over as successor. Podwika will move to a Senior Advisor role to the CEO until he retires on November 5, 2027, with his base salary reduced to $240,000 starting January 1, 2027.
Joseph Podwika steps down as Chief Legal Officer effective November 9, 2026, upon appointment of Ignacio Walker
Podwika becomes Senior Advisor to the CEO; retirement date is November 5, 2027
From January 1, 2027, base salary reduced to $240,000 and no annual bonus or annual equity awards for 2027
Bunge Global SA said its Controller and Chief Accounting Officer, Matt Simmons, will retire effective March 31, 2027, and will stay through the transition period. Richard James, a company veteran, will succeed him as Controller and CAO effective April 1, 2027, and the filing states the retirement is not due to any disagreement on accounting, reporting, operations, policies or practices.
Matt Simmons to retire as Controller and Chief Accounting Officer effective March 31, 2027, and will remain through the transition period
Richard James, age 45, to succeed him effective April 1, 2027
James has worked at Bunge for over fourteen years, most recently as Vice President, Finance Integration and Transformation since December 2022
Filing states the retirement is not the result of any disagreement with the Company on accounting, financial reporting, operations, policies or practices
Bunge reported second quarter 2026 results, with GAAP diluted EPS of $3.47 versus $2.61 a year earlier and adjusted EPS of $2.00 versus $1.31. The company raised its full-year 2026 adjusted EPS outlook to $9.25-$9.75 from $9.00-$9.50 and completed about $250 million of share repurchases under its $2 billion Viterra-related program, which benefits shareholders through higher expected per-share earnings and reduced share count.
Q2 2026 net income attributable to Bunge was $678 million, compared with $354 million in Q2 2025.
Full-year 2026 adjusted EPS outlook raised to $9.25-$9.75 from $9.00-$9.50.
Repurchased about $250 million of shares, completing the $2 billion program related to the Viterra transaction.
Six-month GAAP diluted EPS was $3.81, down from $4.10 a year earlier.
Bunge reported first-quarter 2026 results on April 29, 2026. GAAP diluted EPS fell to $0.35 from $1.48 a year earlier, while adjusted EPS rose slightly to $1.83 from $1.81, and the company raised its full-year 2026 adjusted EPS outlook to $9.00-$9.50 from $7.50-$8.00. For shareholders, the higher outlook sits alongside a sharp drop in reported profit, driven by a $336 million mark-to-market timing swing.
Q1 2026 GAAP diluted EPS was $0.35 versus $1.48; net income attributable to Bunge was $68 million versus $201 million
Q1 2026 adjusted diluted EPS was $1.83 versus $1.81, excluding mark-to-market timing differences and certain gains and charges
Full-year 2026 adjusted EPS outlook raised to $9.00-$9.50 from $7.50-$8.00
Net interest expense outlook raised to $620-$660 million from $575-$625 million; cash used for operating activities was $541 million
On March 31, 2026, Bunge and certain subsidiaries amended their trade receivables securitization program, increasing its aggregate size by $500 million to $2 billion and cutting the accordion feature from $1 billion to $500 million. Recourse to Bunge is generally limited to its first loss position as subordinated lender, apart from repurchase obligations for ineligible receivables, and the filing describes the changes as otherwise substantially unchanged.
Aggregate program size increased by $500 million to a total of $2 billion, dated March 31, 2026
Accordion feature reduced by $500 million, from $1 billion to $500 million
A U.S. subsidiary was added as a seller, a German subsidiary was removed, and a Canadian subsidiary may join subject to conditions
Bunge retains repurchase obligations for ineligible receivables and a first loss position as subordinated lender
Bunge's board approved a special, one-time performance-based incentive program for senior officers, including the CEO, tied to cumulative run-rate cost synergy targets over 2026 to 2028. The program was set up to support integration of the Viterra Limited acquisition, and awards vest only if performance targets are met.
Board approved the Executive Integration Incentive Program on March 26, 2026, on recommendation of the Compensation Committee.
Performance period runs January 1, 2026 through December 31, 2028, measured on cumulative run-rate cost synergy targets.
CEO Gregory Heckman was granted 63,281 PBRSUs; CFO John Neppl received 12,099 and Chief Legal Officer Joseph Podwika received 3,900.
Bunge reported fourth-quarter and full-year 2025 results on February 4, 2026. Net sales rose to $23.8 billion in the quarter from $13.5 billion a year earlier, but GAAP diluted EPS fell to $0.49 from $4.36, and net income attributable to Bunge fell to $95 million from $602 million. The company also expects 2026 adjusted EPS of $7.50 to $8.00.
Q4 2025 GAAP diluted EPS was $0.49 vs. $4.36 a year earlier; adjusted EPS was $1.99 vs. $2.13
Full-year 2025 GAAP diluted EPS was $4.93 vs. $7.99; adjusted EPS was $7.57 vs. $9.19
Full-year 2025 net sales were $70.3 billion vs. $53.1 billion, and net income attributable to Bunge was $816 million vs. $1.14 billion
2026 outlook: adjusted EPS of $7.50 to $8.00; Investor Day scheduled for March 10
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Bunge Global filing is on SEC EDGAR ↗. 8-K briefs of other companies →